Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $21.8 million.

  • Arcutis Biotherapeutics' Non-Current Assets rose 5954.97% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.9 million, marking a year-over-year increase of 6567.73%. This contributed to the annual value of $13.1 million for FY2024, which is 1952.62% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Non-Current Assets stood at $21.8 million for Q3 2025, which was up 5954.97% from $19.7 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Non-Current Assets registered a high of $21.8 million during Q3 2025, and its lowest value of $5.0 million during Q2 2022.
  • Its 5-year average for Non-Current Assets is $11.1 million, with a median of $11.4 million in 2023.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Non-Current Assets soared by 95856.03% in 2021 and then plummeted by 1398.36% in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Non-Current Assets (Quarter) stood at $5.4 million in 2021, then surged by 120.64% to $11.9 million in 2022, then dropped by 7.87% to $10.9 million in 2023, then increased by 19.53% to $13.1 million in 2024, then skyrocketed by 66.45% to $21.8 million in 2025.
  • Its Non-Current Assets was $21.8 million in Q3 2025, compared to $19.7 million in Q2 2025 and $20.4 million in Q1 2025.